ATNM - Volume dana dhuwit perusahaan Actinium Pharmaceuticals, Inc.

Logo korporat perusahaan actiniumpharma.com (ATNM)

Actinium Pharmaceuticals focuses on combating blood cancer, overcoming isotope logistics complexities and regulatory barriers by outsourcing clinical trials to external partners. This cash balance chart demonstrates the impact of these factors, where the current parameter equals 0.03. To hedge against raw material shortages, the firm is developing close cooperation with contract manufacturing sites to ensure uninterrupted drug production.

Actinium Pharmaceuticals Inc - Volume dana dhuwit perusahaan ATNM (periode 04.07.2022 - 21.11.2026)

Rincian metrik keuangan lan pasar Actinium Pharma (ATNM)

Pambiji fundamental perusahaan:Actinium Pharmaceuticals
Sampel barang Actinium Pharmaceuticals, Inc.

This metric measures the volume of immediately available cash, determining the business's resilience to operating losses and market shocks through an analysis of the liquidity balance. The trend on the cash liquidity chart is critically important for Actinium Pharmaceuticals (ATNM), as the development of radiotherapy requires significant expenditures prior to product commercialization and the transition to generating a stable free cash flow.